Lacto-N-biose I (LNB), termed a Type
1 disaccharide,
is an important building block of human milk oligosaccharides. It
shows promising prebiotic activity by stimulating the proliferation
of many gut-associated bifidobacteria and thus displays good potential
in infant foods or supplements. Enzymatic and microbial approaches
to LNB synthesis have been studied, almost all of which involve glycosylation
of LNB phosphorylase as the final step. Herein, we report a new and
easier microbial LNB synthesis strategy through the route “lactose
→ lacto-N-triose II (LNTri II) → lacto-N-tetraose (LNT) → LNB”. A previously constructed
LNT-producing Escherichia coli BL21(DE3)
strain was engineered for LNB biosynthesis by introducing Bifidobacterium bifidum LnbB. LNB was efficiently
produced, accompanied by lactose regeneration. Genomic integration
of key pathway genes related to LNTri II and LNT synthesis was performed
to enhance LNB titers. The final engineered strain produced 3.54 and
26.88 g/L LNB by shake-flask and fed-batch cultivation, respectively.